Moffitt Cancer Center — Tampa, Florida

Public research footprint of Moffitt Cancer Center, compiled from the ClinicalTrials.gov public registry.

2,199

Registered studies

690

Active

345

Recruiting now

1,106

Completed

348

Stopped or withdrawn

Most-studied conditions

Metastatic Non-Cutaneous Melanoma · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Stage IIIB Lung Cancer AJCC v8 · Lung Non-Squamous Non-Small Cell Carcinoma

Recently updated registry entries

NCT03775265 — Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle… (Active Not Recruiting)
NCT03712605 — Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After… (Active Not Recruiting)
NCT03528642 — Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Moffitt Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.